Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs

Researchers at Texas A&M University have developed a novel laser technique called TRIP that directly measures the quantum forces shaping proteins and their interactions with pharmaceutical compounds. This Raman-based approach allows for the real-time observation of molecular forces, such as pi-pi stacking, within living systems rather than relying on static computer models or indirect inference. For the pharmaceutical sector, this breakthrough offers a predictive tool to expedite drug discovery and enhance the precision of therapies for conditions ranging from viral infections to cancer and neurodegenerative diseases.

The research team at Texas A&M’s Institute for Quantum Science and Engineering, led by Dr. Narangerel Altangerel and Dr. Philip Hemmer, invented the TRIP technique to capture the "hidden architecture" of life at the atomic level. Unlike traditional methods such as X-ray crystallography or mass spectroscopy that rely on indirect inference, TRIP uses a laser to record unique vibrational signals from chemical bonds. Specifically, the team identified that the "benzene ring breathing" vibration in the amino acid phenylalanine serves as a sensitive reporter for pi-pi stacking—a subtle quantum interaction that acts as "biology’s Velcro" to hold protein and DNA structures together.

In a critical proof-of-concept study involving the SARS-CoV-2 main protease (Mpro), the TRIP technique successfully uncovered how the viral protein physically rearranged itself during activation. More importantly, the system accurately predicted how effectively specific antiviral drugs would bind to and inhibit the protein by measuring tiny frequency shifts in molecular vibrations. This ability to observe real-time changes allows researchers to evaluate the strength of pharmaceutical candidates long before they reach clinical trials, potentially reducing the high costs and failure rates associated with early-stage drug development.

The implications for the pharmaceutical industry extend far beyond virology, offering a new paradigm for precision medicine where therapies are engineered around fundamental forces. In oncology, TRIP could be utilized to evaluate drugs designed to disrupt the protein networks that drive tumor growth, while in Alzheimer’s research, it may help identify compounds that stabilize healthy proteins to prevent neurodegeneration. Supported by the National Institutes of Health, Google, and the Air Force Office of Scientific Research, this non-invasive technique aims to expedite the testing and prescreening of drugs across a broad spectrum of human health challenges.